Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. (Q42820746)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

main subject

cell line

0 references

neoplastic stem cells

1 reference

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Michael Hsiao

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Chi-Tai Yeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Alexander T H Wu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Peter M-H Chang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kuan-Yu Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chia-Ning Yang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Shuenn-Chen Yang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chun-Chi Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yu-Lun Kuo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Pei-Ying Lee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Yu-Wen Liu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chueh-Chuan Yen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Pei-Jung Lu

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jin-Mei Lai

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Liang-Shun Wang

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chih-Hsiung Wu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Jeng-Fong Chiou

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Pan-Chyr Yang

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Chi-Ying F Huang

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

language of work or name

English

0 references

publication date

28 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

1180-1188

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

9 March 2020

0 references

0 references

0 references

0 references

0 references

0 references

Cancer statistics, 2012

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

The cancer stem cell: premises, promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Epithelial to mesenchymal transition by TGFβ-1 induction increases stemness characteristics in primary non small cell lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

High-affinity interaction of tyrosine kinase inhibitors with the ABCG2 multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Using a stem cell-based signature to guide therapeutic selection in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Module map of stem cell genes guides creation of epithelial cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Effect of an epidermal growth factor receptor inhibitor in mouse models of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Stem cells in the etiology and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

"Stemness": transcriptional profiling of embryonic and adult stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

EZH2 is essential for glioblastoma cancer stem cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Wnt signaling in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Antipsychotic drug doses and neuroleptic/dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Trifluoperazine-induced conformational change in Ca(2+)-calmodulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Trifluoperazine regulation of calmodulin binding to Fas: a computational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Implication of Egr-1 in trifluoperazine-induced growth inhibition in human U87MG glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Trifluoperazine induces domain formation in zwitterionic phosphatidylcholine but not in charged phosphatidylglycerol bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201207-1180OC

10.1164/RCCM.201207-1180OC

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23024022%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference